课题基金 / 基金详情

Abnormal STAT3 signaling and aberrant O-glycosylation of IgA1 in IgA nephropathy

Abnormal STAT3 signaling and aberrant O-glycosylation of IgA1 in IgA nephropathy
IgA 肾病中 STAT3 信号异常和 IgA1 异常 O-糖基化
批准号:
8949844
负责人:
Colin Robert Reily
金额:
$15.42万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-08-01 至 2020-07-31

项目摘要

项目成果

Colin Robert Reily的其他基金

相似基金

相关文献

中文摘要
翻译
 描述(由申请人提供):NIDDK的K01职业发展奖的这项建议的目的是提高申请者的学习和研究技能,以便过渡到独立的调查人员。该奖项的职业发展方面得到了他的指导团队、相关课程、期刊俱乐部、研讨会、大学中心和致力于加强临床医生和研究人员之间合作的核心的推动。这项建议的研究部分集中在导致进行性肾脏损害的自身免疫性疾病IgA肾病(IgAN),以及自身抗原产生的机制。识别与自身抗原产生有关的机制将有助于开发针对疾病的治疗方法,这在目前的治疗方式中是缺乏的。这给IgAN患者带来了巨大的成本负担,无论是在金钱方面,还是在生活质量方面。申请者的长期目标是成为一名独立的调查员,作为目前的博士后,这将需要更多的培训和经验。这将通过与在分子生物学研究方面拥有丰富经验的导师合作实现,特别是在IgAN和肾脏相关疾病方面。该大学设立了特殊的核心项目,帮助年轻研究人员寻找和撰写拨款,获得适当的合作专业知识,研究培训计划,以及实验室管理课程。IGAN是一种自身免疫性疾病,会导致肾功能下降,40%-50%的患者需要透析和/或移植。在这种自身免疫性疾病中,来自免疫系统的B细胞产生具有异常糖基化的IgA1(称为Gd-IgA1),使身体将IgA1识别为外来抗原。自身抗原Gd-IgA1在IgAN患者中升高,并形成免疫复合体形成的基础,免疫复合体沉积在肾脏中,导致进行性肾脏损害。这项建议的目的是确定患者B细胞中Gd-IgA1产生增加的机制。在IgAN患者B细胞中鉴定出受细胞因子差异调节和过度激活的信号转导和转录激活子3(STAT3)的特异性糖基化酶为我们提供了一个很好的起点。我们建议研究导致IgAN患者信号改变的机制,从而为未来减少自身抗原产生的药物开发提供基础。
英文摘要
 DESCRIPTION (provided by applicant): The purpose of this proposal for the K01 Career Development Award from the NIDDK is to enhance the learning and research skills of the applicant in order to transition into an independent investigator. The career development aspect of this award is facilitated by his mentoring team, relevant courses, journal clubs, seminars, university centers, and cores dedicated to enhancing collaboration between clinicians and researchers. The research portion of this proposal is focused on the autoimmune disease IgA nephropathy (IgAN), which causes progressive kidney damage, and the mechanisms of autoantigen production. Identification of mechanisms involved in autoantigen production will allow for disease-specific therapies to be developed, which is absent in current therapeutic modalities. This has a huge cost burden on IgAN patients, both in terms of money and quality of life. The long-term goal of the applicant is to become an independent investigator, and as a current postdoc this will require more training and experience. This will be accomplished through collaboration with mentors who have extensive experience in molecular biology research, and specifically IgAN and kidney related diseases. The university has exceptional core programs set up to help young investigators with finding and writing grants, obtaining proper collaborative expertise, research training programs, and lab management courses. IgAN is an autoimmune disease, which leads to decreased kidney function, with 40-50% of patients requiring dialysis and/or transplantation. In this autoimmune disease, B cells from the immune system produce IgA1 that has an aberrant glycosylation (termed Gd-IgA1) that causes the body to recognize IgA1 as a foreign antigen. The autoantigen, Gd-IgA1, is elevated in IgAN patients and forms the basis for immune-complex formation, which deposits in the kidney, leading to progressive kidney damage. The aims of this proposal are to identify mechanisms responsible for elevated Gd-IgA1 production in patient B cells. Identification of specific glycosylation enzymes that are differentially regulated and over activation signal transducer and activator of transcription 3 (STAT3) by cytokines in IgAN patient B cells has provided us with a strong starting point. We propose to investigate mechanisms responsible for altered signaling in IgAN patients, thereby providing bases for future drug development to reduce autoantigen production.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Abnormal cytokine response and autoantigen production in IgA-producing subpopulations in IgA nephropathy
Abnormal STAT3 Signaling and Aberrant O-Glycosylation of IgA1 in IgA Nephropathy
Abnormal STAT3 signaling and aberrant O-glycosylation of IgA1 in IgA nephropathy
海外基金